FEATURE: Proteomics Sector Shows First Symptoms of M&A Fever | GenomeWeb

NEW YORK, April 13 – For months, market watchers have been predicting that the structural proteomics market would undergo a period of consolidation. With too many small companies specializing in narrowly focused technologies, they said, it was only a matter of time before they joined together to provide big pharma with a more complete package. Perhaps that time has come.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.